Sunshine Biopharma (SBFMW) Revenue Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFMW) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 2.34% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 2.91% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1.62% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 42.25% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 10.01% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 14.92% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -87.11% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.23% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 4,158.49% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -9.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.13% |
| Dec 31, 2025 | -10.61% |
| Sep 30, 2025 | 11.64% |
| Jun 30, 2025 | 1.15% |
| Mar 31, 2025 | 18.04% |
| Dec 31, 2024 | 24.93% |
| Sep 30, 2024 | 41.59% |
| Jun 30, 2024 | 67.30% |
| Mar 31, 2024 | 54.09% |
| Dec 31, 2023 | 94.94% |
| Sep 30, 2023 | 4,385.93% |
| Jun 30, 2023 | 3,599.67% |
| Mar 31, 2023 | 3,890.42% |
| Dec 31, 2022 | 4,528.68% |
| Sep 30, 2022 | 163.63% |
| Jun 30, 2022 | 184.27% |
| Mar 31, 2022 | 206.17% |
| Dec 31, 2021 | 203.85% |
| Sep 30, 2021 | 193.74% |
| Jun 30, 2021 | 249.12% |